DGX vs. ABBV
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DGX or ABBV.
Correlation
The correlation between DGX and ABBV is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
DGX vs. ABBV - Performance Comparison
Loading data...
Key characteristics
DGX:
1.26
ABBV:
0.57
DGX:
2.22
ABBV:
0.96
DGX:
1.27
ABBV:
1.15
DGX:
1.85
ABBV:
0.87
DGX:
8.32
ABBV:
2.07
DGX:
3.67%
ABBV:
8.72%
DGX:
21.94%
ABBV:
28.31%
DGX:
-49.46%
ABBV:
-45.09%
DGX:
-0.30%
ABBV:
-14.28%
Fundamentals
DGX:
$19.87B
ABBV:
$325.05B
DGX:
$7.90
ABBV:
$2.34
DGX:
22.53
ABBV:
78.64
DGX:
1.58
ABBV:
0.39
DGX:
1.96
ABBV:
5.67
DGX:
2.87
ABBV:
228.91
DGX:
$10.16B
ABBV:
$57.37B
DGX:
$3.31B
ABBV:
$44.44B
DGX:
$1.95B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, DGX achieves a 19.13% return, which is significantly higher than ABBV's 5.50% return. Over the past 10 years, DGX has underperformed ABBV with an annualized return of 11.52%, while ABBV has yielded a comparatively higher 15.63% annualized return.
DGX
19.13%
8.65%
12.01%
25.80%
12.41%
11.52%
ABBV
5.50%
6.38%
13.63%
14.60%
19.97%
15.63%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DGX vs. ABBV — Risk-Adjusted Performance Rank
DGX
ABBV
DGX vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
DGX vs. ABBV - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.71%, less than ABBV's 3.47% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.71% | 1.96% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% |
ABBV AbbVie Inc. | 3.47% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
DGX vs. ABBV - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for DGX and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
DGX vs. ABBV - Volatility Comparison
The current volatility for Quest Diagnostics Incorporated (DGX) is 7.86%, while AbbVie Inc. (ABBV) has a volatility of 11.11%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
DGX vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DGX vs. ABBV - Profitability Comparison
DGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Quest Diagnostics Incorporated reported a gross profit of 863.00M and revenue of 2.65B. Therefore, the gross margin over that period was 32.5%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
DGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Quest Diagnostics Incorporated reported an operating income of 346.00M and revenue of 2.65B, resulting in an operating margin of 13.1%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
DGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Quest Diagnostics Incorporated reported a net income of 220.00M and revenue of 2.65B, resulting in a net margin of 8.3%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.